Published in Immunity on August 01, 1996
Calreticulin: one protein, one gene, many functions. Biochem J (1999) 3.16
Pathways of antigen processing. Annu Rev Immunol (2013) 2.82
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest (2001) 2.61
MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol (2009) 2.49
Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J (2009) 2.48
Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A (1997) 2.39
CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol (1998) 2.38
Comparative genomics of major histocompatibility complexes. Immunogenetics (2004) 2.31
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A (1997) 2.14
The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J Cell Biol (1997) 2.14
The quality control of MHC class I peptide loading. Curr Opin Cell Biol (2008) 1.91
Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J (2000) 1.91
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med (1999) 1.71
Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol (2004) 1.66
The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J (2001) 1.55
Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S A (2004) 1.49
Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J (2005) 1.47
Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med (2004) 1.43
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (2005) 1.36
TAP deficiency syndrome. Clin Exp Immunol (2000) 1.35
Dual roles for immunity in gastrointestinal cancers. J Clin Oncol (2010) 1.31
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.30
ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J (1998) 1.24
Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. EMBO J (2009) 1.23
The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J Exp Med (1999) 1.22
Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. J Immunol (2010) 1.20
The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med (1998) 1.14
Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J Virol (2004) 1.14
Retracted Lectin-deficient calreticulin retains full functionality as a chaperone for class I histocompatibility molecules. Mol Biol Cell (2008) 1.14
Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J (1999) 1.13
Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc Natl Acad Sci U S A (2001) 1.13
Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway. J Biol Chem (2009) 1.13
Generation and characterization of a preventive and therapeutic HPV DNA vaccine. Vaccine (2007) 1.12
Intracellular assembly and trafficking of MHC class I molecules. Traffic (2009) 1.12
Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines (2011) 1.11
ERp57 does not require interactions with calnexin and calreticulin to promote assembly of class I histocompatibility molecules, and it enhances peptide loading independently of its redox activity. J Biol Chem (2009) 1.11
Deglucosylation of N-linked glycans is an important step in the dissociation of calreticulin-class I-TAP complexes. Proc Natl Acad Sci U S A (1996) 1.10
Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (1997) 1.09
Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96. J Exp Med (1997) 1.06
The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics. J Immunol (2012) 1.05
Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc Natl Acad Sci U S A (1997) 1.05
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts. Cancer Immunol Immunother (2008) 1.04
Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J Virol (2000) 1.01
Folding of thyroglobulin in the calnexin/calreticulin pathway and its alteration by loss of Ca2+ from the endoplasmic reticulum. Biochem J (2003) 0.98
Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution. PLoS Pathog (2015) 0.98
Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking. J Cell Sci (2011) 0.96
HLA-H and associated proteins in patients with hemochromatosis. Mol Med (1997) 0.95
The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol (2011) 0.95
Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Cancer Immunol Immunother (2013) 0.94
Proprotein convertases process Pmel17 during secretion. J Biol Chem (2011) 0.94
Activation of human monocyte cell line U937 via cell surface calreticulin. Cell Stress Chaperones (2001) 0.93
Differential contribution of TAP and tapasin to HLA class I antigen expression. Immunology (2008) 0.93
Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology (2008) 0.92
A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteins. J Biol Chem (2013) 0.92
Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J (2001) 0.92
Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. J Clin Invest (1999) 0.90
Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assembly. Immunology (2005) 0.90
Essential glycan-dependent interactions optimize MHC class I peptide loading. Proc Natl Acad Sci U S A (2011) 0.90
Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. Proc Natl Acad Sci U S A (2013) 0.89
Dynamics of major histocompatibility complex class I association with the human peptide-loading complex. J Biol Chem (2012) 0.88
Influence of the tapasin C terminus on the assembly of MHC class I allotypes. Immunogenetics (2008) 0.88
Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP). Proc Natl Acad Sci U S A (2001) 0.88
Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin Diagn Lab Immunol (2000) 0.87
Identification and regulatory analysis of rainbow trout tapasin and tapasin-related genes. Immunogenetics (2006) 0.87
Cloning and functional analyses of the mouse tapasin promoter. Immunogenetics (2003) 0.87
Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain. Mol Immunol (2011) 0.86
Direct evidence that the N-terminal extensions of the TAP complex act as autonomous interaction scaffolds for the assembly of the MHC I peptide-loading complex. Cell Mol Life Sci (2012) 0.86
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86
What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules? Immunol Res (2010) 0.86
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis. Vaccine (2004) 0.85
Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits. Immunology (2002) 0.85
Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation. Immunology (2001) 0.85
Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology (2002) 0.85
Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun. J Immunol (2008) 0.85
Two polymorphisms facilitate differences in plasticity between two chicken major histocompatibility complex class I proteins. PLoS One (2014) 0.84
Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc Natl Acad Sci U S A (1998) 0.84
Calreticulin recognizes misfolded HLA-A2 heavy chains. Proc Natl Acad Sci U S A (2002) 0.84
TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst. Elife (2015) 0.84
Effect of a tapasin mutant on the assembly of the mouse MHC class I molecule H2-K(d). Immunol Cell Biol (2009) 0.83
The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive. J Immunol (2013) 0.83
iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells. Adv Enzyme Regul (2008) 0.83
Identification of an alternate splice form of tapasin in human melanoma. Hum Immunol (2010) 0.83
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases. Front Immunol (2015) 0.83
Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. Oncoimmunology (2016) 0.82
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice. PLoS One (2013) 0.82
Calreticulin: roles in cell-surface protein expression. Membranes (Basel) (2014) 0.81
Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function. Mol Immunol (2015) 0.81
Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex. J Virol (2008) 0.81
Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules. J Immunol (2011) 0.81
Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing. J Exp Med (1998) 0.81
Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates. Immunol Rev (2015) 0.80
Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules. Br J Cancer (1999) 0.80
Transient association of calnexin and calreticulin with newly synthesized G1 and G2 glycoproteins of uukuniemi virus (family Bunyaviridae). J Virol (1999) 0.80
Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination. J Mol Med (Berl) (2013) 0.79
Adapter-mediated substrate selection for endoplasmic reticulum-associated degradation. J Biol Chem (2009) 0.79
Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization. J Immunol (2014) 0.79
Newly discovered viral E3 ligase pK3 induces endoplasmic reticulum-associated degradation of class I major histocompatibility proteins and their membrane-bound chaperones. J Biol Chem (2012) 0.79
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol (2001) 5.48
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics (1985) 5.30
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 4.69
An activating immunoreceptor complex formed by NKG2D and DAP10. Science (1999) 4.56
Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol (1998) 4.54
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (1992) 4.53
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 4.40
Glycosylation and the immune system. Science (2001) 4.39
Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J (1986) 3.78
HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell (1995) 3.64
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (1990) 3.54
Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (1990) 3.44
A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1994) 3.33
NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol (1987) 3.06
Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct (1979) 3.02
Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments. Proc Natl Acad Sci U S A (1973) 2.96
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A (1988) 2.64
HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 2.54
Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2001) 2.49
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol (2001) 2.43
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics (2001) 2.43
Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci U S A (1986) 2.42
Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev (1985) 2.41
Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A (2000) 2.40
Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A (1997) 2.39
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A (2000) 2.38
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A (2005) 2.34
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci U S A (1989) 2.32
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A (1987) 2.31
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A (1991) 2.25
MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity (2001) 2.19
Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol (1982) 2.18
A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science (1997) 2.18
Defective antigen processing in GILT-free mice. Science (2001) 2.16
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A (1997) 2.14
Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (1991) 2.14
Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci U S A (1994) 2.08
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A (1992) 2.08
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1985) 1.98
MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature (1994) 1.93
CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol (1995) 1.92
Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol (2006) 1.91
Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity (1998) 1.90
Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity (1994) 1.87
High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J Immunol (1990) 1.85
Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature (1992) 1.83
Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A (1974) 1.80
Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (1992) 1.79
Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1985) 1.79
Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J Exp Med (1991) 1.77
HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med (1996) 1.77
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol (2001) 1.76
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol (1998) 1.69
Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics (1989) 1.67
Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J Virol (1994) 1.66
Purification of papain-solubilized histocompatibility antigens from a cultured human lymphoblastoid line, RPMI 4265. J Biol Chem (1975) 1.66
Antisera to human B-lymphocyte membrane glycoproteins block stimulation in mixed lymphocyte culture. Nature (1975) 1.64
Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J Immunol (1990) 1.60
DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med (2000) 1.59
In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity (1994) 1.59
Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex. Proc Natl Acad Sci U S A (1984) 1.59
A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain. Proc Natl Acad Sci U S A (1990) 1.59
Lemierre syndrome: forgotten but not extinct--report of four cases. Radiology (1999) 1.58
HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity (1998) 1.58
Allelic repertoire of the human MHC class I MICA gene. Immunogenetics (1996) 1.57
The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J (2001) 1.55
Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science (1997) 1.55
Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl Acad Sci U S A (1991) 1.54
Monoclonal antibody to HLA-A3. Hybridoma (1982) 1.54
Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol (1985) 1.52
P1 and cosmid clones define the organization of 280 kb of the mouse H-2 complex containing the Cps-1 and Hsp70 loci. Immunogenetics (1994) 1.52
Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system. Proc Natl Acad Sci U S A (1980) 1.50
Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol (1990) 1.49
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol (2005) 1.48
The immunoglobulin-like structure of human histocompatibility antigens. Transplant Rev (1974) 1.48
CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity (2001) 1.47
Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity (2000) 1.47
Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity (1994) 1.46
Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J Biol Chem (2000) 1.45
Transferrin receptors on human B and T lymphoblastoid cell lines. Biochim Biophys Acta (1979) 1.44
Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med (1995) 1.44
Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci U S A (1992) 1.43
Pleural involvement in the carcinoid syndrome. Q J Med (1993) 1.42
Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J Immunol (1993) 1.41
Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A (1991) 1.40
Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol (1992) 1.40
The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J Immunol (1992) 1.39
HLA-A2 as a target for cell-mediated lympholysis: evidence from immunoselected HLA-A2 negative mutant cell lines. Hum Immunol (1980) 1.39
Processing and delivery of peptides presented by MHC class I molecules. Curr Opin Immunol (1996) 1.38
Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J Immunol (1993) 1.38